This inventor holds 1 USPTO granted patent. Top assignee: Texas Tech University System. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Mikelis Constantinos: Innovator in Neuroinflammation Treatment
Introduction
Mikelis Constantinos is an accomplished inventor based in Amarillo, TX (US). He has made significant contributions to the field of therapeutic treatments, particularly in combating neuroinflammation associated with various neurological disorders. His innovative work has the potential to improve the quality of life for many patients suffering from conditions such as Alzheimer's disease and Parkinson's disease.
Latest Patents
Mikelis Constantinos holds a patent for "Substituted bisphenylalkylurea compounds and methods." This patent discloses a composition and method for therapeutic treatment that effectively combats neuroinflammation caused by diseases and disorders such as Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The class of urea compounds acts by blocking targeted receptors in the brain that contribute to increased inflammation. The compositions inhibit combinations of receptors, including the H1 receptor, H2 receptor, dopamine transporter (DAT), and/or 5HT3C receptor, leading to a decrease in brain edema. Additionally, the DAT inhibitory effects help maintain dopamine levels in patients.
Career Highlights
Mikelis Constantinos is affiliated with the Texas Tech University System, where he continues to advance his research and development efforts. His work is characterized by a commitment to addressing critical health challenges through innovative solutions. With a focus on neuroinflammation, he has positioned himself as a key figure in the field of therapeutic treatments.
Collaborations
Mikelis Constantinos collaborates with Nadezhda German, contributing to the advancement of research in neuroinflammation and therapeutic methods. Their partnership exemplifies the importance of teamwork in driving innovation and achieving impactful results.
Conclusion
Mikelis Constantinos is a notable inventor whose work in neuroinflammation treatment holds promise for improving patient outcomes in neurological disorders. His dedication to research and innovation continues to pave the way for future advancements in the field.